CHOP chemotherapy plus rituximab compared with CHOP alone in diffuse large B-cell lymphoma patients

被引：0
|
作者：
Poddubnaya, I [1 ]
Osmanov, D [1 ]
Babicheva, L [1 ]
Falaleeva, N [1 ]
机构：
[1] NN Blokhin Canc Res Ctr, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
478
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [41] Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System
    Elena Cabrera, Maria
    Pena, Camila
    Leon, Pilar
    Lois, Vivianne
    Rojas, Hernan
    Vega, Valeska
    Pizarro, Alvaro
    Calderon, Susana
    Rojas, Christine
    Aspillaga, Augusto
    Luisa Gonzalez, M.
    Intriago, Marvila
    Rojas, Bernardita
    Hales, Cecilia
    Oliva, Jacqueline
    Romero, Monica
    Capurro, Marisa
    Castillo, Jorge J.
    JCO GLOBAL ONCOLOGY, 2022, 8 : e2200165
  • [42] Successful treatment of diffuse large B-cell lymphoma following Waldenstrom's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab
    Uchino, K
    Sameshima, H
    Miyamoto, T
    Iino, T
    Kato, K
    Henzan, H
    Aoki, K
    Nagafuji, K
    Gondo, H
    Harada, M
    INTERNAL MEDICINE, 2004, 43 (02) : 131 - 134
  • [43] Limited-Stage Diffuse Large B-cell Lymphoma in Head and Neck Treated With CHOP or Rituximab-CHOP (R-CHOP) Plus Radiation Therapy
    Ohga, S.
    Nakamura, K.
    Shioyama, Y.
    Sasaki, T.
    Nonoshita, T.
    Yoshitake, T.
    Asai, K.
    Hirata, H.
    Honda, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S618 - S618
  • [44] R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma
    Kreher, Stephan
    Lammer, Felicitas
    Augustin, Dieter
    Pezzutto, Antonio
    Baldus, Claudia D.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (01) : 70 - 76
  • [45] Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP
    Yoon, Dok Hyun
    Choi, Dae Ro
    Ahn, Heui June
    Kim, Shin
    Lee, Dae Ho
    Kim, Sang-We
    Park, Bong-Hee
    Yoon, Sun Och
    Huh, Jooryung
    Lee, Sang-Wook
    Suh, Cheolwon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (02) : 149 - 157
  • [46] KI-67 EXPRESSION IS PREDICTIVE OF PROGNOSIS IN PATIENTS OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP
    Suh, C.
    Yoon, D. H.
    Sohn, B. S.
    Kim, J. E.
    Yoo, C. H.
    Kim, S.
    Lee, D. H.
    Huh, J. R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 402 - 403
  • [47] Cost-effectiveness of chop-like chemotherapy plus rituximab versus chop-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma
    Ferrara, F.
    Ravasio, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 223 - 223
  • [48] Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients
    Wang, HongBiao
    Lin, YingCheng
    Li, ZhiFeng
    Wu, YueRong
    Yang, ZhengYuan
    Gao, ShiHua
    Lin, FangFang
    CLINICAL LABORATORY, 2023, 69 (01) : 1 - 8
  • [49] Neutropenic and Non-Neutropenic Fever In Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-CHOP Chemotherapy
    Park, Silvia
    Kim, Won Seog
    Kim, Seok Jin
    Hong, Jung Yong
    BLOOD, 2013, 122 (21)
  • [50] Surgical resection combined with chop chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma
    Yamaguchi, Tetsuya
    Takahashi, Hiroshi
    Kagawa, Ryuzaburou
    Takeda, Ryoji
    Sakata, Shingo
    Nishizaki, Daisuke
    Takamatsu, Teruyuki
    Iwasa, Yoko
    HEPATO-GASTROENTEROLOGY, 2008, 55 (84) : 891 - 894
12345